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Purpose: To determine whether a mutation in the RP1-like protein 1 (RP1L1) gene is present in a Japanese patient with
sporadic occult macular dystrophy (OMD) and to examine the characteristics of focal macular electroretinograms (ERGs)
of the patient with genetically identified OMD.
Methods: An individual with OMD underwent detailed ophthalmic clinical evaluations including focal macular ERGs.
Mutation screening of all coding regions and flanking intron sequences of the RP1L1 gene were performed with DNA
sequencing analysis in this case with OMD.
Results: A new RP1L1 mutation (c.3596 C>G in exon 4) was identified. The variant c.3596 C>G in exon 4 resulted in
the substitution of cysteine for serine at amino acid position 1199. The serine at position 1199 is well conserved among
the RP1L1 family in other species. Four out of five computational assessment tools predicted that this mutation is damaging
to the protein function. This mutation was not present in 294 control alleles. The waveform of focal macular ERGs recorded
from the patient with OMD had a depolarizing pattern, simulating the ERG waveforms observed after the hyperpolarizing
bipolar cell activity is blocked.
Conclusions: We have demonstrated in a Japanese patient the possibility that sporadic OMD may also be caused by an
RP1L1 mutation. The waveform of focal macular ERGs elicited from the OMD patient with the RP1L1 mutation showed
a depolarizing pattern. This characteristic is the same as reported for the focal macular ERGs of OMD.
Occult macular dystrophy (OMD; OMIM 613587) is an
inherited macular dystrophy characterized by a progressive
decrease in visual acuity with an essentially normal fundus
and  normal  fluorescein  angiograms  [1,2].  The  full-field
electroretinograms (ERGs) are normal; however, the focal
macular ERGs and multifocal ERGs (mfERGs) recorded from
the  macular  area  are  abnormal  [1-3].  Despite  normal
ophthalmoscopic findings, spectral domain-optical coherence
tomography (SD-OCT) has shown morphological changes in
the retina in the macular area [4-8]. Several studies have
reported various degrees of disruption of the inner segment/
outer segment (IS/OS) junction and the cone outer segment
tip (COST) line [4-8].
The hereditary form of OMD is an autosomal dominant
trait; however, sporadic patients have also been reported [3,
9].  The  gene  responsible  for  the  disease  was  recently
identified as the RP1-like protein 1 (RP1L1) in four families
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with autosomal dominant OMD [10]. The RP1L1 gene has
been  identified  through  sequence  analyses  of  human  and
mouse genomes [11,12]. The human RP1L1 gene is encoded
in four exons that span 50 kb on chromosome 8p. The length
of the mRNA of RP1L1 is more than 7 kb, but the exact length
varies among individuals because of the presence of several
length  polymorphisms.  RP1L1  encodes  a  protein  with  a
minimal length of 2,400 amino acids and a predicted weight
of 252 kDa.
The expression of RP1L1 is limited to the retina, and
appears to be specific to photoreceptors [12]. The RP1L1 gene
was also found to be conserved in distant vertebrates [11].
Knockout mice lacking the RP1L1 protein have reduced ERG
amplitudes and progressive photoreceptor degeneration [13].
The study of RP1L1−/− mice also showed that the RP1L1
protein is located in the axoneme of the outer segments and
connecting  cilia  exclusively  in  rod  photoreceptors.  The
RP1L1  protein  appears  not  to  be  expressed  in  cone
photoreceptors  in  mice,  although  more  than  97%  of  the
photoreceptors  in  mice  are  rods  [13].  However,
immunohistochemical analysis of the RP1L1 of Cynomolgus
monkeys with the human RP1L1 antibody showed that RP1L1
Molecular Vision 2012; 18:1031-1039 <http://www.molvis.org/molvis/v18/a109>
Received 27 November 2011 | Accepted 20 April 2012 | Published 24 April 2012
© 2012 Molecular Vision
1031was expressed in rod and cone photoreceptors [10]. Because
the  amino  acid  sequence  of  human  RP1L1  is  only  39%
identical to that of the mouse, researchers have suggested that
the primate RP1L1 might have different functional roles in the
cone photoreceptors of the retina than that of other species
[10].
We have identified a new mutation in the RP1L1 gene in
a patient with clinical characteristics of OMD: abnormal focal
macular ERGs and blurring of the IS/OS junction and the
disappearance of the COST line in SD-OCT images. The
fundus examination, fluorescein angiograms, and full-field
ERGs were normal in this case. The mutation is an amino acid
substitution of cysteine for serine in exon 4 of the RP1L1 gene
that  has  not  been  reported  in  the  Single  Nucleotide
Polymorphism (SNP) database and was also not detected in
any of the 294 normal control alleles. The serine at position
1199 is well conserved among the RP1L1 family in other
species.  Four  out  of  five  computational  assessment  tools
(PolyPhen-2,  SIFT,  PMut,  Align  GVGD,  and
MutationTaster) predicted that this mutation is damaging to
the protein function. A segregation of the mutation and the
disease was found in one affected member and one unaffected
member of the same family.
METHODS
The protocol conformed to the tenets of the Declaration of
Helsinki and was approved by the Institutional Review Board
of  the  Nippon  Medical  School  and  the  ethics  review
committees  of  the  National  Hospital  Organization  Tokyo
Medical Center. Written informed consent was obtained from
all patients after the nature and possible consequences of the
study were explained.
Clinical  studies:  The  ophthalmological  examinations
included best-corrected visual acuity (BCVA) measurements,
refraction, slit-lamp biomicroscopy, ophthalmoscopy, fundus
photography, perimetry, SD-OCT, fluorescein angiography
(FA), full-field ERGs, focal ERGs, and mfERGs. The visual
fields were determined with the Goldman perimetry and the
Humphrey Visual Field Analyzer (model 745i; Carl Zeiss
Meditec, Inc., Dublin, CA). The Swedish interactive threshold
algorithm standard strategy was used with program 30–2 of
the Humphrey Visual Field Analyzer. The OCT images were
recorded using a SD-OCT (Carl Zeiss Meditec) on this patient
and normal controls. Full-field scotopic and photopic ERGs
were  recorded  using  an  extended  testing  protocol
incorporating  the  International  Society  for  Clinical
Electrophysiology of Vision standards [14]. The full-field
ERGs were used to assess retinal function under scotopic and
photopic states.
Focal macular electroretinograms: Focal macular ERGs
were recorded with a commercial Focal Macular ERG system
(ER80; Kowa Company, Tokyo, Japan, and PuREC; Mayo
Company,  Nagoya,  Japan)  using  a  bipolar  contact  lens
electrode (MY type Electrode; Mayo Company). The stimulus
and background lights were integrated into an infrared fundus
camera [15-17]. The size of the stimulus spot was 15° in
diameter and was placed on the macula by observing the
infrared image of the retina on a monitor. The white stimulus
and background illumination were generated by light-emitting
diodes that had maximal spectral emissions at 440 to 460 nm
and 550 to 580 nm, respectively. The luminances of the stimuli
and background were 115.7 cd/m2 and 8.0 cd/m2. The duration
of the stimulation was 100 ms. The responses were amplified
and filtered with digital band pass filters from 5 to 200 Hz.
Three  hundred  responses  were  summed  with  a  stimulus
frequency  of  5  Hz.  The  a-wave,  b-wave,  d-wave,  and
oscillatory potentials (OPs) were evaluated.
Multifocal  electroretinograms:  The  mfERGs  were
recorded  using  a  commercial  mfERG  system  (LE-4000,
Tomey, Nagoya, Japan; LE4100; Mayo Company, Inazawa,
Japan). This system uses basically the same technology as the
Visual Evoked Response Imaging System [18]. The visual
stimuli consisted of 37 hexagonal elements with an overall
subtense  of  approximately  50°.  The  luminance  of  each
hexagon was independently modulated between black (2.47
cd/m2) and white (200.4 cd/m2) according to a binary m-
sequence at 75 Hz. The surround luminance was set at 75.4
cd/m2.
Mutation analysis: Blood samples were collected from
the patient, and genomic DNA was isolated from peripheral
white blood cells using a blood DNA isolation kit (NucleoSpin
Blood XL; Macherey Nagel, Düren, Germany). The DNA was
used as the template to amplify the RP1L1 gene. Coding
regions  and  flanking  introns  of  the  RP1L1  gene  were
amplified  with  polymerase  chain  reaction  (PCR)  using
primers produced by Greiner Bio-One (Tokyo, Japan). Primer
sequences  are  listed  in  Table  1.  The  PCR  products  were
purified (ExoSAP-IT; USB Corp., Cleveland, OH) and were
used  as  the  template  for  sequencing.  Both  strands  were
sequenced on an automated sequencer (Bio Matrix Research;
Chiba,  Japan).  The  identified  mutations  and  coding
polymorphisms were assayed in 294 control chromosomes
from 147 healthy Japanese individuals with direct sequencing
except  the  length  polymorphism  region.  To  sequence  the
length polymorphism region of the RP1L1 gene, the amplified
PCR  products  were  subcloned  into  the  StrataClone  PCR
cloning vector (Stratagene; La Jolla, CA). At least five cloned
products  from  this  case  and  20  control  individuals  were
sequenced on an automated sequencer.
Computational  assessment  of  missense  mutation:  The
effect of a missense mutation on the encoded protein was
predicted with the PolyPhen-2, SIFT, PMut, Align GVGD,
and  MutationTaster  online  tools  [19-24].  PolyPhen-2  is  a
software tool that predicts the possible impact of amino acid
substitutions on the structure and function of human proteins
using straightforward physical and evolutionary comparative
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1032considerations. SIFT generates multiple alignments of the
sequence  over  different  species  to  look  at  the  conserved
sequences of a gene; it assesses the conserved amino acid
positions and analyzes the effect of missense changes on the
conserved structure of proteins over the course of evolution.
The SIFT tool assigns a score to the mutations, and a score of
<0.05 is considered potentially damaging. PMut is software
aimed at annotating and predicting pathological mutations.
Align  GVGD  combines  the  biophysical  characteristics  of
amino  acids  and  protein  multiple  sequence  alignments  to
predict where missense substitutions in genes of interest fall
in a spectrum from enriched deleterious to enriched neutral.
MutationTaster  evaluates  the  disease-causing  potential  of
sequence alterations.
Statistical analysis: We calculated the 95% confidence
intervals (CI) of the results of the focal macular ERGs of
normal controls. There were 25 men and 21 women whose
age ranged from 23 to 60 years (mean, 38.04±8.33 years) in
TABLE 1. SEQUENCES OF OLIGONUCLEOTIDE PRIMERS USED IN THIS STUDY AND PCR PRODUCT SIZE.
Fragment name Forward primer (5′-3′) Reverse primer (5′-3′) Product size
(bp)
RP1L1–2A GAGACAGGAAATGCCAATCC CCGCAACTGCTGAGCAGTGG 471
RP1L1–2B CCTCTGCTCTGATAAGAAGC TCCATGTGAGTATTTTGACC 373
RP1L1–3 CCTCCAGCTAGTGATAGAGG GATTGACAGTACTGAGAAGG 498
RP1L1–4A TTCCTTTATCCTGATGCTGC CCAAAGACTTCCCTGCATCC 509
RP1L1–4B TGTGGGAGGGCTACCCTTGG GCTGACGAGTCCGAAGAAGC 508
RP1L1–4C CTATGCATAGATGGAGCAGG GTTACAGAGGAGTCCAGTGG 536
RP1L1–4D CAATGTCCTCACCCAGCAGC TCCAACCTGCAGAACCAAGG 494
RP1L1–4E GACTCCTGCTCAAAATCTGG GGACACCCTCTCCTGATTGG 784
RP1L1–4F GGACAGCAGTCCCTGGAAGG ACTGCACCGCCTCTTCTTGC 937
RP1L1–4G AAACACAGTGCAAGAAGAGG AGGCTCAAGCTGGGAGCCACTCTGC variable
RP1L1–4H GGGAAAGGCTCCCAGGAAGATGACC TTCTGCACCTTCTGACTCTGGCTGG 1470
RP1L1–4I CACAGAGGAACCCACAGAGC GAGAAGGCCGAGAGGTTTCG 522
RP1L1–4J CAAGAGAGAGCTCCAGAAGC TCTGTTGAGTCTCTGGCTCC 547
RP1L1–4K GACAAAGATCCCAAACTCGG AGAGTCAGAAGATGTAGAGG 836
RP1L1–4L TGAAGGGGAGATGCAAGAGG GAGTGGGCCTGTCCTCAGGGACTGG 821
RP1L1–4M AGGCTTCTGAAAGCAGCAGC ACTATGGACATCTCCAGTGG 517
Figure 1. Fundus photographs (A, B)
and fluorescein angiograms (C, D) of
this case showing no abnormal findings.
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1033this control group. We recorded focal macular ERGs from
either of the eyes of normal controls and calculated the 95%
CI of the amplitudes of the a-waves and the b-waves, the
implicit time of the a-waves and b-waves, the potentials at
70 ms after the stimulus was turned on, and the time of the
recovery of the b-wave to the baseline.
RESULTS
Case report: A 52-year-old woman complained of a gradual
decrease in vision in both eyes during the past two to three
years. Family history revealed no other members with any eye
diseases,  including  her  parents  who  were  deceased.  Her
BCVAs were 20/63 in the right eye and 20/50 in the left eye.
The fundus examination, fluorescein angiography, and full-
field ERG results were within the normal limits (Figure 1A-
D and Figure 2). The visual fields were full with the Goldman
perimetry, but a relative central scotoma was detected in both
eyes with the Humphrey Visual Field Analyzer.
Spectral  domain  optical  coherence  tomography:  The  SD-
OCT images of this case showed a blurred IS/OS junction and
COST line at the foveal center (Figure 3D,F). In the peripheral
macula area, the COST line was absent, and only the blurred
IS/OS junction was visible in this case (Figure 3C,E).
Focal  macular  electroretinograms  and  multifocal
electroretinograms: A severe reduction in the a-waves of the
focal  macular  ERGs  was  found  in  this  case  (Figure  4).
Although the b-waves were large, their shapes were abnormal.
The b-waves rose to a peak, and the potential was maintained
longer than normal. The plateau region of the b-wave was
significantly elevated above the baseline potential (Figure 4,
Figure 2. Full-field electroretinograms
(ERGs)  recorded  according  to  the
International  Society  for  Clinical
Electrophysiology  of  Vision  (ISCEV)
standards protocol in this case. The rod,
combined  rod-cone,  cone,  oscillatory
potentials, and 30-Hz flicker full-field
ERGs are shown. The results of full-
field ERGs are within the normal limits
in this case.
Figure  3.  Spectral-domain  optical
coherence  tomography  (SD-OCT)
findings of the eyes in normal controls
(A, B) and in this case (C-F). Images
from right eyes (C, D) and left eyes (E,
F)  are  shown.  Images  at  lower
magnification  (A,  C,  E)  and  higher
magnification (B, D, F) are shown. The
SD-OCT findings for the eyes in this
case show obvious blurring of the IS/OS
junction and the COST line. The COST
line  disappeared  in  the  peripheral
macula area in this case.
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1034arrow).  To  analyze  this  characteristic,  we  quantified  the
potentials at 70 ms after the stimulus was turned on, and the
recovery  time  of  the  descending  slope  of  b-wave  to  the
baseline from the peak of the b-wave. We calculated the 95%
confidence intervals (CI) for the amplitudes of the a-waves
and b-waves, the implicit times of the a-waves and b-waves,
the potentials at 70 ms after the stimulus turns on, and the time
of the recovery of the b-waves to the baseline obtained from
the normal controls (Figure 5). Among these six parameters,
the amplitudes of the a-waves, the implicit times of the b-
waves, the potentials at 70 ms after the stimulus was turned
on, and the time of the recovery of the descending slope of the
b-wave to the baseline obtained from both eyes of this case
were outside the range of the standard deviation and the 95%
CI  of  the  normal  controls  (Figure  5).  Especially,  the
amplitudes of the a-waves, the potentials at 70 ms after the
stimulus was turned on, and the time of the recovery of the
descending slope of the b-wave to the baseline obtained from
this  case  were  severely  affected.  The  amplitudes  of  the
mfERGs in the foveal area were severely reduced in this case
(Figure 4).
Molecular genetic findings: Mutation analysis of the RP1L1
gene in this case showed three missense mutations. There was
a c.2578 C>T in exon 4 with a substitution of tryptophan
(TGG) for arginine (CGG) at amino acid position 860, a c.
3596 C>G in exon 4 with a substitution of cysteine (TGT) for
serine (TCT) at amino acid position 1199, and a c. 4484 C>G
in exon 4 with a substitution of arginine (CGC) for proline
(CCC)  at  amino  acid  position  1495.  The  amino  acid
substitution  at  position  860  and  1495  has  already  been
reported in the SNP database and is found in a high percentage
of the normal population. A mutation at amino acid position
1199 has not been reported in the SNP database or in earlier
reports  (Figure  6A).  The  serine  at  position  1199  is  well
conserved among the RP1L1 family in other species (Figure
6B). This mutation was predicted to be probably damaging
with a score of 0.999 by PolyPhen-2. The SIFT tool analysis
revealed a score of 0 and predicted that the replaced amino
acid  is  potentially  damaging  and  would  not  be  tolerated.
PMut  predicted  that  this  mutation  is  pathological.  Align
GVGD predicted this mutation as class C65, which means it
most likely interferes with the protein function. Out of five
computational  assessments,  only  MutationTaster  predicted
this  mutation  as  a  polymorphism.  We  confirmed  that  the
mutation in this case was segregated with the disease in one
affected member and one unaffected member of the family
(Figure 6C). The unaffected member of the family in Case 1
underwent clinical examination, including BCVAs, slit-lamp
biomicroscopy,  fundus  ophthalmoscopy,  OCT,  and  focal
ERGs. All examination findings were normal. This mutation
was not present in 300 control alleles. This mutation p.S1199C
has  been  registered  in  GenBank  with  accession  number
AB684329.
Figure  4.  Results  of  focal  macular
electroretinograms  (ERGs)  and
multifocal ERGs. Focal macular ERGs
and oscillatory potentials recorded from
a normal subject and this case are shown
(top). The amplitude of the a-wave of
this case was severely reduced, and the
plateau  region  was  significantly
elevated (arrows). The topographic map
and  the  local  responses  of  multifocal
ERGs recorded from the normal subject
and this case are shown (bottom). The
amplitudes  in  the  foveal  area  were
severely reduced in this case.
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1035Bowne et al. [11] reported that RP1L1 mRNA is variable
due to the presence of a 48 bp polymorphic coding repeat.
They reported that as many as six 48 bp repeats have been
observed in normal controls. In this case, one allele contains
a 48 bp repeat, and the other allele contains three 48 bp repeats
(Figure 6D). There are variations of only two amino acids in
the length polymorphism region from this case compared to
the reference sequence (NP_849188). One variation with the
substitution of E to G in the 14th amino acid of the length
polymorphism  region  was  in  a  previous  report  [12]
(AAN86962,  AAN86963,  and  AAN86964).  The  other
variation with the substitution of G to V in the ninth amino
acid of the length polymorphism region was found in more
than 10 normal control alleles from a Japanese population.
These variations of the length polymorphisms of RP1L1 with
one and three repeats have been registered in GenBank with
accession numbers AB684331 and AB684332, respectively.
DISCUSSION
The mutation found in the RP1L1 gene in this case was a
missense  mutation  with  cysteine  substituted  for  serine  at
amino acid position 1199. This residue is well conserved
among the RP1L1 family in other species, suggesting the
importance of this amino acid residue for RP1L1 function.
Four out of five computational analysis tools predicted this
mutation is damaging to the protein function. We did not find
this mutation in the sister of the patient with normal vision,
although she was the only other family member we were able
to test. To decide whether this mutation was pathogenic, we
need to examine more family members and a larger number
Figure 5. Plot of the amplitudes of the a-
waves, b-waves, and the implicit time of
the a-waves, b-waves, the potentials at
70ms after the stimulus turns on, and the
time of the recovery of b-wave to the
baseline for normal controls. There were
25  men  and  21  women  whose  age
ranged  from  23  to  60  years  (mean,
38.04±8.33 years) in this control group.
The boxes represent the 95% confidence
interval  ranges,  the  horizontal  line
represents  mean  values,  and  the  bars
represent  standard  deviation.  Data
recorded from this case are plotted at
indicated mark.
Molecular Vision 2012; 18:1031-1039 <http://www.molvis.org/molvis/v18/a109> © 2012 Molecular Vision
1036of normal controls. However, the phenotype of this case was
typical of OMD, and thus the mutation in this case was most
likely pathogenic.
The photoreceptor IS/OS junction and the COST line can
be detected in the SD-OCT images of normal eyes [25-28].
Recently, several degrees of disruption of the IS/OS junction
and/or COST line in the SD-OCT images of patients with
OMD have been reported [4-8]. In our case, the IS/OS junction
and the COST line appeared blurred in the SD-OCT images
similar to previous reports.
Researchers  have  emphasized  that  the  key  to
differentiating  OMD  from  other  diseases,  such  as  optic
neuritis or psychological disorders, is the recording of focal
macular ERGs from the central retina [1-3]. Focal macular
ERGs have a unique waveform when elicited by long-duration
stimuli [29]. As shown in this patient, the waveform of focal
macular ERGs recorded from patients with OMD with long-
duration stimuli had a depolarizing pattern, simulating the
ERG waveforms observed after the hyperpolarizing bipolar
cell  activity  is  blocked  [30-33].  Researchers  have
demonstrated that by blocking hyperpolarizing bipolar cells
with cis-2,3-piperidine dicarboxylic acid or kynurenic acid in
monkeys,  the  a-  and  d-waves  of  photopic  ERGs  become
smaller and the plateau between the b- and d-waves remains
elevated above the baseline potential [34]. Full-field cone
ERG  in  some  human  retinal  dystrophies  show  a  similar
depolarizing  pattern  [29,35].  Kondo  et  al.  [29]  reported
similar focal macular ERGs elicited with 100 ms stimuli from
a patient with glittering crystalline deposits in the posterior
fundus. The waveform of the focal macular ERGs of this case
Figure 6. DNA analysis for c.3596C>G mutation and deduced amino acids of length polymorphism region of the RP1-like protein 1
(RP1L1) gene and the pedigree of the family with RP1L1 gene mutation. A: Sequence chromatograms for this case (top) and the normal control
(bottom) are shown. This case had a c.3596 C>G mutation in exon 4. B: Alignment of S1199 in the RP1L1 family proteins. Amino acid-
sequence alignments of RP1L1 from 10 species reported in the NCBI database are shown. Amino acid residues of S1199 in humans and
conserved residues from other species are boxed. The asterisks indicate completely conserved residues. S1199 is well conserved in all species
reported. C: We confirmed that the mutation in Case 1 was segregated with the disease in one affected member and one unaffected member
of the family. D: Deduced amino acids (AA) of repeated regions of the RP1L1 length polymorphism. In this case, one allele contains a 16
AA, and the other allele contains three 16 AA repeats. Variations of amino acids from reference sequence of RP1L1 are shown in red. Those
variations are within normal limits.
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1037was similar to those reported for patients with OMD [31-33].
Because this case had a putative disease-causing mutation of
the RP1L1 gene, we suggest the reduced amplitude of the a-
wave and the persistent plateau between the b- and d-waves
of the focal macular ERGs elicited with long-duration stimuli
might be specific markers that could help diagnose OMD.
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